液体活检与CT对比:1065例转移性肿瘤患者肿瘤负荷定量比较
该回顾性单中心研究纳入1065例转移性癌症患者,比较液体活检肿瘤分数(TF)与增强CT所示总肿瘤体积(TTV)的相关性。TF与TTV仅呈弱相关(R²=0.17),以TTV>151 cm³和TF>10%为阈值时AUC为0.74,敏感度57%、特异度80%,提示TF虽与TTV相关但不能准确代表CT所测肿瘤负荷。
要点
- TF>10%与TTV>151 cm³联合判断时AUC为0.74,敏感度57%、特异度80%。
- TF预测TTV的线性模型R²=0.17,Spearman相关系数ρ=0.41(P<.001)。
- TTV>37 cm³预测液体活检可贡献状态的AUC为0.71(95%CI: 0.67, 0.76)。
核心结论
- 液体活检TF与CT所示TTV虽相关,但TF不能准确代表CT所测肿瘤负荷。
研究设计与样本
- 回顾性单中心研究,纳入1065例转移性癌症患者,于2021年1月至2023年1月间行TF检测并同期行增强CT;按训练集745例和验证集320例拆分。
关键影像表现/征象
- 共标注56 288个病灶,主要位于肺(n=20 334)、淋巴结(n=11 651)和肝(n=10 277)。
- TTV通过勾画每个病灶最大轴位层面并累加所有病灶体积计算。
- 763例液体活检可贡献、254例不可贡献、48例失败。
诊断标准与关键数值
- TF>10%定义为高肿瘤分数。
- TTV>151 cm³且TF>10%时,AUC为0.74(95%CI: 0.71, 0.78),敏感度57%(204/359)、特异度80%(525/658)。
- TTV>37 cm³预测液体活检可贡献状态的AUC为0.71(95%CI: 0.67, 0.76)。
临床应用与阅片要点
- 阅片时可测量TTV作为肿瘤负荷参考,但需注意其与液体活检TF仅弱相关(ρ=0.41)。
- 验证队列中肝脏病灶体积与液体活检可贡献状态显著相关。
局限性
- 原文为回顾性单中心研究。
- TF预测TTV的线性模型R²=0.17,相关性较弱。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Tumor fraction (TF) at liquid biopsy is a potential noninvasive marker for tumor burden, but validation is needed. Purpose To evaluate TF as a potential surrogate for tumor burden, assessed at contrast-enhanced CT across diverse metastatic cancers. Methods This retrospective monocentric study included patients with cancer and metastatic disease, with TF results and contemporaneous contrast-enhanced CT performed between January 2021 and January 2023. The total tumor volume (TTV), representing CT tumor burden, was calculated by adding all lesion volumes and was computed by using manually outlined annotations of each lesion on the largest surface of the axial slice. TF greater than 10% was considered high. A training-validation split was applied. Correlations between TF and TTV were assessed using regression models and Spearman correlation coefficients. Receiver operating characteristic curve analysis established the TTV cutoff. The metastatic site, histology type, and TTV were used to predict liquid biopsy contributory status. Results Among 1065 patients (median age, 62 years [IQR: 53, 70]; 537 female), 56 288 lesions were annotated, mostly in the lung (n = 20 334), lymph nodes (n = 11 651), and liver (n = 10 277). A total of 763 liquid biopsies were contributive, 254 were noncontributive, and 48 failed. The training and validation sets included 745 and 320 patients, respectively. TF helped predict TTV with the linear model (R2 = 0.17; ρ = 0.41; P < .001). The TTV and TF categories achieved an area under the receiver operating characteristic curve (AUC) of 0.74 (95% CI: 0.71, 0.78), with an optimal cutoff of 151 cm3 for TTV and a TF cutoff of 10%. The sensitivity was 57% (204 of 359) and the specificity was 80% (525 of 658). TTV helped predict contributory status, with an AUC of 0.71 (95% CI: 0.67, 0.76) and an optimal cutoff greater than 37 cm3. Liver lesion volumes were significantly associated with a contributory liquid biopsy in the validation cohort. Conclusion While correlated, TF at liquid biopsy did not accurately represent the TTV at CT. © RSNA, 2024 Supplemental material is available for this article. See also the editorial by Koh in this issue.
引用
- Dawi L, Belkouchi Y, Lawrance L, et al. Liquid Biopsy versus CT: Comparison of Tumor Burden Quantification in 1065 Patients with Metastases. Radiology. 2024. PMID: 39589242. doi:10.1148/radiol.232674
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。